By interacting with specific receptors in the body, they slow down gastric motility which creates a sense of fullness, causing individuals to consume fewer calories, which can lead to faster weight loss
STEP Trial Evidence 15% Average Weight Reduction The semaglutide STEP trial program produced some of the most impressive weight loss outcomes ever documented in a pharmaceutical trial average 14.9% body weight reduction at 68 weeks
We don't know the exact mechanisms yet of how these medications influence alcohol consumption, but our guess is that GLP-1 drugs can reduce the release of dopamine in the brain's motivation center, making previously rewarding behaviors, like over-drinking, less enjoyable, says Michelle Cardel, Ph.D., M.S., RD, chief nutrition officer at WeightWatchers
Learn about the impact of hydration on appetite from our experts Are weight loss injections safe